Tech Company Financing Transactions
Synthetic Genomics Funding Round
On 3/31/2013, Synthetic Genomics raised $10 million in financing from Biotechonomy Ventures and Threshold Ventures.
Transaction Overview
Company Name
Announced On
3/31/2013
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Undisclosed
Investors
Biotechonomy Ventures (Juan Enriquez)
Threshold Ventures (Steven Jurvetson)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
11149 North Torrey Pines Rd.
La Jolla, CA 92037
USA
La Jolla, CA 92037
USA
Phone
Website
Email Address
Overview
Synthetic Genomics Inc. was founded to commercialize genomic-driven technologies. Our scientific strength lies in the decades of pioneering research by founders, J. Craig Venter, Ph.D., Nobel Laureate Hamilton O. Smith, M.D., and the leading scientific teams they have assembled.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Oliver Fetzer
Founder
Hamilton Smith
Founder
Craig Venter
Vice President
Robert Brown
Vice President
Timothy Cooley
Vice President
Margaret Dunbar
Vice President
Daniel Gibson
Vice President
Kurt Kamrud
VP - Bus. Development
Anthony Artuso
VP - Bus. Development
Rachel Cervantes
VP - Finance
Douglas Miller
VP - General Counsel
Robert Cutler
VP - General Counsel
Celia Eckert
VP - Human Resources
Natasha Bowman
Browse more venture capital transactions:
Prev: 3/31/2013: XYDO venture capital transaction
Next: 3/31/2013: RecycleBank venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. All VC database entries on this site are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs